These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 22300975

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A large proportion of prediabetes and diabetes goes undiagnosed when only fasting plasma glucose and/or HbA1c are measured in overweight or obese patients.
    Cosson E, Hamo-Tchatchouang E, Banu I, Nguyen MT, Chiheb S, Ba H, Valensi P.
    Diabetes Metab; 2010 Sep; 36(4):312-8. PubMed ID: 20627649
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Predicting isolated postchallenge hyperglycaemia: a new approach; Tehran Lipid and Glucose Study (TLGS).
    Hosseinpanah F, Rambod M, Reza Ghaffari HR, Azizi F.
    Diabet Med; 2006 Sep; 23(9):982-9. PubMed ID: 16922704
    [Abstract] [Full Text] [Related]

  • 5. Validating the CANRISK prognostic model for assessing diabetes risk in Canada's multi-ethnic population.
    Robinson CA, Agarwal G, Nerenberg K.
    Chronic Dis Inj Can; 2011 Dec; 32(1):19-31. PubMed ID: 22153173
    [Abstract] [Full Text] [Related]

  • 6. Gender modulates the relationship between body weight and plasma glucose in overweight or obese subjects.
    Seghieri G, Tesi F, Anichini R, De Bellis A, Fabbri G, Malagoli R, Franconi F.
    Diabetes Res Clin Pract; 2008 Apr; 80(1):134-8. PubMed ID: 18077049
    [Abstract] [Full Text] [Related]

  • 7. Body adiposity and type 2 diabetes: increased risk with a high body fat percentage even having a normal BMI.
    Gómez-Ambrosi J, Silva C, Galofré JC, Escalada J, Santos S, Gil MJ, Valentí V, Rotellar F, Ramírez B, Salvador J, Frühbeck G.
    Obesity (Silver Spring); 2011 Jul; 19(7):1439-44. PubMed ID: 21394093
    [Abstract] [Full Text] [Related]

  • 8. Risk prediction models for the development of diabetes in Mauritian Indians.
    Gao WG, Qiao Q, Pitkäniemi J, Wild S, Magliano D, Shaw J, Söderberg S, Zimmet P, Chitson P, Knowlessur S, Alberti G, Tuomilehto J.
    Diabet Med; 2009 Oct; 26(10):996-1002. PubMed ID: 19900231
    [Abstract] [Full Text] [Related]

  • 9. Fasting-based estimates of insulin sensitivity in overweight and obesity: a critical appraisal.
    Ruige JB, Mertens IL, Bartholomeeusen E, Dirinck E, Ferrannini E, Van Gaal LF.
    Obesity (Silver Spring); 2006 Jul; 14(7):1250-6. PubMed ID: 16899806
    [Abstract] [Full Text] [Related]

  • 10. Prescreening tools for diabetes and obesity-associated dyslipidaemia: comparing BMI, waist and waist hip ratio. The D.E.S.I.R. Study.
    Balkau B, Sapinho D, Petrella A, Mhamdi L, Cailleau M, Arondel D, Charles MA, D.E.S.I.R. Study Group.
    Eur J Clin Nutr; 2006 Mar; 60(3):295-304. PubMed ID: 16278693
    [Abstract] [Full Text] [Related]

  • 11. A multivariate logistic regression equation to screen for dysglycaemia: development and validation.
    Tabaei BP, Engelgau MM, Herman WH.
    Diabet Med; 2005 May; 22(5):599-605. PubMed ID: 15842515
    [Abstract] [Full Text] [Related]

  • 12. Dysglycaemia and its risk factors in an urban Fulani population of northern Nigeria.
    Sabir AA, Isezuo SA, Ohwovoriole AE.
    West Afr J Med; 2011 May; 30(5):325-30. PubMed ID: 22752819
    [Abstract] [Full Text] [Related]

  • 13. Performance of the Finnish Diabetes Risk Score and a Simplified Finnish Diabetes Risk Score in a Community-Based, Cross-Sectional Programme for Screening of Undiagnosed Type 2 Diabetes Mellitus and Dysglycaemia in Madrid, Spain: The SPREDIA-2 Study.
    Salinero-Fort MA, Burgos-Lunar C, Lahoz C, Mostaza JM, Abánades-Herranz JC, Laguna-Cuesta F, Estirado-de Cabo E, García-Iglesias F, González-Alegre T, Fernández-Puntero B, Montesano-Sánchez L, Vicent-López D, Cornejo-Del Río V, Fernández-García PJ, Sánchez-Arroyo V, Sabín-Rodríguez C, López-López S, Patrón-Barandio P, Gómez-Campelo P, SPREDIA-2 Group.
    PLoS One; 2016 May; 11(7):e0158489. PubMed ID: 27441722
    [Abstract] [Full Text] [Related]

  • 14. Sensitivity and specificity of waist circumference as a single screening tool for identification of overweight and obesity among Malaysian adults.
    Kee CC, Jamaiyah H, Geeta A, Ali ZA, Safiza MN, Suzana S, Khor GL, Rahmah R, Jamalludin AR, Sumarni MG, Lim KH, Faudzi YA, Amal NM.
    Med J Malaysia; 2011 Dec; 66(5):462-7. PubMed ID: 22390102
    [Abstract] [Full Text] [Related]

  • 15. Gestational diabetes: an alternative, patient-friendly approach for using the diagnostic 100-g OGTT in high-risk populations.
    Agarwal MM, Dhatt GS, Punnose J.
    Arch Gynecol Obstet; 2006 Mar; 273(6):325-30. PubMed ID: 16328394
    [Abstract] [Full Text] [Related]

  • 16. Fasting plasma glucose (FPG) and the risk of impaired glucose tolerance in obese children and adolescents.
    Maffeis C, Pinelli L, Brambilla P, Banzato C, Valzolgher L, Ulmi D, Di Candia S, Cammarata B, Morandi A.
    Obesity (Silver Spring); 2010 Jul; 18(7):1437-42. PubMed ID: 19851301
    [Abstract] [Full Text] [Related]

  • 17. Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose.
    Abdul-Ghani MA, Williams K, DeFronzo R, Stern M.
    Diabetes Care; 2006 Jul; 29(7):1613-8. PubMed ID: 16801587
    [Abstract] [Full Text] [Related]

  • 18. Oral glucose tolerance test in Italian overweight/obese children and adolescents results in a very high prevalence of impaired fasting glycaemia, but not of diabetes.
    Cambuli VM, Incani M, Pilia S, Congiu T, Cavallo MG, Cossu E, Sentinelli F, Mariotti S, Loche S, Baroni MG.
    Diabetes Metab Res Rev; 2009 Sep; 25(6):528-34. PubMed ID: 19496065
    [Abstract] [Full Text] [Related]

  • 19. Performance indicators and validity of serum fructosamine assay as a diagnostic test in a screening program for diabetes mellitus.
    Mula-Abed WA, Al-Naemi AH.
    Saudi Med J; 2003 May; 24(5):477-84. PubMed ID: 12847621
    [Abstract] [Full Text] [Related]

  • 20. Comparison of indices of insulin resistance with metabolic syndrome classifications to predict the development of impaired fasting glucose in overweight and obese subjects: a 3-year prospective study.
    Shand BI, Scott RS, Lewis JG, Elder PA, Frampton CM.
    Int J Obes (Lond); 2009 Nov; 33(11):1274-9. PubMed ID: 19721448
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.